DOI:
10.1055/s-00033990
TH Open
LinksClose Window
References
de Jong LA, Dvortsin E, Janssen KJ, Postma MJ.
Cost-effectiveness analysis for apixaban in the acute treatment and prevention of venous thromboembolism in the Netherlands.
Clin Ther 2017;
39 (02) 288-302.e4
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.